Sri Kosuri of Octant - The Future of Drugs, Synthetic Biology, and Complex Diseases

In this episode of Build The Future, we talk with Sri Kosuri, CEO & co-founder of Octant. At Octant they engineer biology to design multi-targeted small molecule drug leads to transform the treatment of society’s most complex diseases.  We talk about their drug discovery engine, engineering biology, genetics, advances in biotech, and much more!

Links Mentioned

To listen to more episodes and stay connected, follow along at:

Don’t forget to leave a review and subscribe.
Have a great week and until next time, go build!